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Summary 
The zebrafish is an outstanding model for intravital imaging of inflammation due to 
its optical clarity and the ability to express fluorescently label specific cell types by 
transgenesis. However, although several transgenics labelling myeloid cells exist, 
none allows distinction of macrophages from neutrophils. This prevents simultaneous 
imaging and examination of the individual contributions of these important leukocyte 
subtypes during inflammation. 
 
We therefore used BAC recombineering to generate a transgenic 
Tg(fms:GAL4.VP16)i186, in which expression of the hybrid transcription factor Gal4-
VP16 is driven by the fms (CSF1R) promoter. This was then crossed to a second 
transgenic expressing a mCherry-nitroreductase fusion protein under the control of 
the Gal4 binding site (the UAS promoter), allowing intravital imaging of mCherry 
labelled macrophages. 
 
Further crossing this compound transgenic with the neutrophil transgenic 
Tg(mpx:GFP)i114 allowed clear distinction between macrophages and neutrophils 
and simultaneous imaging of their recruitment and behaviour during inflammation. 
Compared with neutrophils, macrophages migrate significantly more slowly to an 
inflammatory stimulus. Neutrophil number at a site of tissue injury peaked around 6h 
post injury before resolving, while macrophage recruitment increased until at least 
48h. We show that macrophages were effectively ablated by addition of the prodrug 
Metronidazole, with no effect on neutrophil number. Crossing with Tg(Fli1:GFP)y1 
transgenic fish enabled intravital imaging of macrophage interaction with 
endothelium for the first time, revealing that endothelial contact is associated with 
faster macrophage migration. 
 
Tg(fms:GAL4.VP16)i186 thus provides a powerful tool for intravital imaging and 
functional manipulation of macrophage behaviour during inflammation.  
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Introduction 
Mammalian studies have demonstrated a complex partnership between neutrophils 
and monocyte/macrophages during inflammation (1). This interplay is central to host 
defence, but is also a major contributor to atherosclerosis (2-5). Unfortunately, 
intravital imaging of the interaction between monocyte/macrophages, neutrophils and 
the vasculature is challenging in conventional mammalian models. 
 
The zebrafish has emerged as a powerful model for the intravital study of 
inflammation (6-10). The early embryo is near transparent, thanks to its small size and 
limited pigmentation (11). Combining these advantages with the ability to perform 
mutagenesis and transgenesis has transformed the zebrafish into a unique model for 
biomedical research (12, 13). 
 
Innate immune responses are evolutionarily ancient, and the functional divergence of 
macrophages and neutrophils predates the evolutionary split between teleost fish and 
mammals (14). The myeloid lineage develops rapidly, with functional macrophages 
appearing by 12-16h post fertilisation (hpf), and neutrophils by 16hpf (15). 
Structurally, biochemically and functionally, these cells demonstrate close homology 
to their mammalian counterparts (15), although macrophages of early zebrafish 
embryos are tissue resident (16), rather than experiencing a circulating monocyte 
phase. This is analogous to the primitive macrophages found in the developing 
mammalian embryo prior to definitive haematopoesis (17). 
 
Intravital imaging of inflammation in zebrafish is reliant upon transgenic lines 
expressing fluorescent reporters in the cell types of interest, several of which exist. 
Transgenics using the pu.1 promoter to drive reporter expression label all myeloid 
cells (18-20). Several neutrophil transgenics are available, with Tg(mpx:GFP)i114 
being most neutrophil-specific (6, 21). The mych:YFP line generated in an enhancer 
trap screen is also highly specific for a subset of neutrophils making up 50% of total 
neutrophil number (22). The Lysozyme C promoter labels a subset of both neutrophils 
and macrophages (23) while fli1:GFP labels a poorly-defined subset of myeloid cells, 
in addition to its predominant expression in endothelial cells (24, 25). Thus, no 
transgenic is currently available that distinguishes macrophages from neutrophils. The 
fms promoter (CSF1R) has been shown to be macrophage-specific in mice (26, 27) 
and is not expressed in zebrafish neutrophils (22, 28). It therefore represents a 
possible strategy to distinguish macrophages from neutrophils. 
 
Using Bacterial Artificial Chromosome (BAC) transgenesis allows highly tissue-
specific expression compared with promoter fragment approaches. However, 
chromosomal integration of the modified BAC is inefficient, and hundreds of 
embryos need to be injected and screened to maximise the chance of identifying a 
single founder. The availability of the Tol2kit (29) provides more efficient 
integration, generating transgenics more rapidly with higher success rates, but is 
unable to deliver vectors as large as a BAC (30). We used the fms promoter to drive 
expression of Gal4 (a yeast transcription factor) rather than a fluorescent reporter 
directly. This has the advantage that once established, a Gal4 transgenic can then be 
crossed with any other transgenic expressing dominant negative proteins, fluorescent 
reporters, or combinations of these under the control of the UAS promoter to which 
Gal4 binds (31). This therefore allows tissue-specific overexpression of any UAS 
construct, providing a tool that can be applied to a wide range of intravital imaging 
and mechanistic studies. 
 
In this paper we detail generation and characterization of a novel 
Tg(fms:GAL4.VP16)i186 transgenic zebrafish. We demonstrate that this labels a 
population of migratory phagocytic myeloid cells that are recruited to sites of tissue 
injury and do not co-express the neutrophil marker myeloperoxidase, indicating these 
cells are macrophages. Crossing with transgenic lines expressing fluorescent reporters 
in endothelial cells or neutrophils allowed simultaneous imaging of macrophages with 
each cell type, and revealed distinct differences in the kinetics of recruitment of 
neutrophils and macrophages to an inflammatory stimulus. We also observed that 
macrophages in contact with endothelium migrate more rapidly than macrophages 
within non-vascular tissue. Finally, expressing nitroreductase selectively in 
macrophages enabled their ablation without altering neutrophil number. 
Tg(fms:GAL4.VP16)i186 therefore allows novel approaches to intravital imaging of 
inflammation. 
 Materials and Methods 
All experiments were performed under UK Home Office Project License 40/3031 or 
40/3325 and conformed to the ethical requirements of our institution. The names first 
used to describe transgenics within this manuscript conforms with standard 
nomenclature (32), but some are subsequently shortened to aid clarity. 
 
Generation of a fms:Gal4.VP16 BAC 
The fms gene was identified in the ENSEMBL database (ENSDARG00000007889). 
BAC libraries (Imagenes) were screened by PCR using the following primer pair: 
 Forward GGATGCTCTCGATGGCTAAA 
Reverse CGTCACATGGACACACTCCT 
BAC clone HUKGB735K06247Q (from the keygene 735 BAC library) was found to 
contain fms and appropriate amounts of flanking sequence. A Gal4.VP16 construct 
was inserted into the fms start site by BAC recombineering as described (33). An I-
scei digestion site was inserted to allow linearization, by targeting the cmr cassette 
with an appropriately constructed vector. 
 
Generation of a transgenic line expressing Gal4-VP16 under the fms promoter 
The BAC construct was linearised and injected into wildtype (AB) zebrafish embryos 
at the one-cell stage. These were raised to adulthood and founders identified by 
screening genomic DNA of offspring for Gal4-VP16 by PCR. A single founder was 
identified and subsequent generations incrossed to produce the line 
Tg(fms:Gal4.VP16)i186.  
 Breeding of compound transgenic zebrafish. 
We generated a Tg(UAS-E1b:nfsB.mCherry)i149 line expressing a fusion protein of 
nitroreductase and mCherry under the UAS promoter (the construct was a kind gift of 
Michael Parsons, Johns Hopkins University). The Tg(fms:Gal4.VP16)i186 founder 
was crossed to Tg(UAS-E1b:nfsB.mCherry)i149 and offspring expressing mCherry 
were raised to adulthood. The resulting compound transgenic adults (formally termed 
Tg(fms:Gal4.VP16)i186; Tg(UAS:nfsB.mCherry)i149, hereafter referred to as 
fms:nfsB.mCherry for clarity) were crossed to Tg(mpx:GFP)i114 (6) and 
Tg(Fli1:GFP)y1 (25) fish and offspring expressing both mCherry and GFP raised to 
adulthood to produce stable lines. Compound transgenics expressing both Gal4.VP16, 
nfsB.mCherry and either mpx:GFP or fli1:GFP are hereafter referred to as fms/mpx or 
fms/fli1 compound transgenics respectively. 
 
Confocal imaging and tailfin injury 
Confocal microscopy was performed on anaesthetized embryos immobilized in 1% 
low melt point agarose (Sigma) within a chamber slide on a Perkin Elmer UltraVIEW 
Vox spinning disk confocal microscope. Where required, an inflammatory response 
was induced by tail transection as previously described (6). Volocity software was 
used to quantify cell number and track cell movement to measure migration speed. 
 
Myeloid/macrophage cell depletion 
Myeloid cell depletion was achieved by morpholino antisense knockdown of the 
transcription factor pu.1 as previously described (13, 34). Specific macrophage 
depletion was achieved by incubation of fms:mpx embryos in 5mM of Metronidazole 
for 15hrs before imaging as previously described (35). 
 
Results 
fms:nfsB.mCherry transgenic larvae were observed under fluorescent and confocal 
microscopy from 16h post fertilization (hpf). No mCherry expression was seen at 16h 
or 24h, but was easily detectable by 48hpf. Fig. 1A shows composite DIC and 
confocal micrographs of a typical 48hpf fms:nfsB.mCherry transgenic embryo. Cells 
with the morphology and location typical of xanthophores strongly expressed 
mCherry (Fig. 1B) as predicted from their known expression of fms (19, 20). In 
keeping with their role as epidermal pigment cells, timelapse confocal microscopy 
revealed this xanthophore population to be entirely static over at least 24h of 
recording. 
 
Characterisation of fms positive immune cell population 
From 48hpf, timelapse confocal microscopy revealed a second, non-xanthophore 
population of mCherry expressing cells (Fig. 1C) that were likely to represent 
macrophages. To define their nature, we sought to establish whether these cells were 
migratory, derived from the myeloid lineage, and whether they expressed mpx. 
 
The non-xanthophore cells labelled by the transgene displayed the localisation, 
morphology, migratory capacity and behaviour of zebrafish macrophages as described 
in previous reports (16). Timelapse imaging revealed mCherry expressing 
macrophage-like cells migrating through the tissue (Fig. 2, Supplemental Movie 1). 
 Cells derived from the myeloid lineage are dependent on the transcription factor pu.1, 
loss of which leads to failure of myeloid cell development. Injection of morpholino-
modified antisense constructs that knockdown pu.1 expression (previously shown to 
efficiently and specifically ablate myeloid cells (13, 18, 34, 36)) abolished the 
migratory mCherry expressing population, leaving xanthophores unaffected. Fig. 3 
shows representative confocal projections of the fms:nfsB.mCherry embryos injected 
with control or pu.1 morpholinos imaged over the yolk sac and caudal vein, both sites 
of predilection for zebrafish macrophages. Although xanthophores persist in pu.1 
morphant embryos (yellow arrowheads) the migratory macrophage-like cells (white 
arrows) were effectively abolished by pu.1 knockdown. Thus, the fms:nfsB.mCherry 
labels a motile cell population derived from the myeloid lineage. 
 
To determine whether fms:nfsB.mCherry labelled neutrophils, we crossed the 
fms:nfsB:mCherry line with the neutrophil specific Tg(mpx:GFP)i114 line (6). Triple 
compound transgenic embryos (fms/mpx) contained entirely separate populations of 
GFP-expressing neutrophils and mCherry-expressing putative macrophages (Fig. 4 
and supplemental Movie 2). There was no co-localisation of mCherry with GFP. 
mCherry positive macrophages can be seen phagocytosing cell debris in 
Supplemental Movie 2 (arrowed). Thus, the fms:nfsB.mCherry transgene labels a 
migratory, phagocytic myeloid cell entirely distinct from myeloperoxidase-expressing 
neutrophils. We therefore concluded that these cells are indeed macrophages. 
 
Intravital analysis of macrophage and neutrophil behaviour 
To observe recruitment of both neutrophils and macrophages to a site of inflammation 
simultaneously, we injured compound fms/mpx transgenic larvae by tailfin transection 
as previously described (6, 37). Fig. 5 shows a representative confocal timelapse 
acquired up to 14h after injury. Supplemental Movie 3 shows recruitment of 
neutrophils and macrophages to the site of injury acquired every 60s over the first 
12h. As described previously, neutrophils are rapidly recruited to the site of injury, 
peaking at 6h post injury, before numbers decline to baseline by 48h. In contrast, 
recruitment of macrophages occurs over a longer period, progressively increasing 
until at least 48h after injury (Fig 6A). Supplemental Movie 4 shows a higher power 
acquisition recorded every 10s for 80min at the site of injury revealing complex 
interactions between macrophages and neutrophils. 
 
Mammalian neutrophils are thought to migrate more rapidly than macrophages into 
sites of inflammation (38), though limited data exists on intravital simultaneous 
comparisons. In order to test whether this holds true for zebrafish myeloid cells, we 
measured their migration speed to the site of tailfin injury. In keeping with their more 
rapid recruitment to an inflammatory stimulus, zebrafish neutrophils migrated 
significantly faster than macrophages. Migration speed of each cell type remained 
constant between 4-8h after induction of an inflammatory response (Fig. 6B). This is 
in keeping with in vitro data showing that macrophages and neutrophils utilise 
different mechanisms for migration through extracellular matrix and respond to 
different chemotactic signals (39). 
 
Intravital imaging of macrophage/endothelial interactions 
Macrophages play an important role in development and remodelling of the 
vasculature (40), though few intravital models exist in which the relationship between 
these cell types can be studied during vessel formation and remodelling. We therefore 
generated fms/fli1 compound transgenics with mCherry-expressing macrophages and 
GFP-expressing endothelial cells. Macrophages were frequently located in close 
apposition to the abluminal surface of the caudal vein (Fig. 7A), previously 
demonstrated to be a site of predilection of macrophages (16). Despite the close 
relationship of macrophages to the vasculature, no evidence of transmigration either 
into or from the circulation was observed, in keeping with previous reports indicating 
zebrafish macrophages are analogous to the mammalian primitive macrophage and do 
not undergo a circulating monocyte-like phase. 
 
Strikingly, macrophages were frequently seen migrating along the abluminal surface 
of endothelial cells, a manner of migration not previously described to our knowledge 
(Fig. 7B and Supplemental movie 5). This raised the possibility that macrophages 
use endothelial cells as physical or molecular guidance cues to aid migration. We 
therefore compared migration speeds of macrophages in contact with endothelium 
with those migrating through the tissue. Macrophages migrating along endothelial 
cells migrated 63±9% faster than macrophages within tissue (Fig 7C), suggesting 
macrophage/endothelial interaction may facilitate macrophage migration or that 
macrophage behaviour is altered when in contact with endothelium. 
 
Macrophage ablation using nitroreductase expression 
We have demonstrated the capacity of the fms:nfsB.mCherry line to express reporter 
constructs in macrophages in vivo. To demonstrate that additional functional 
constructs can also be delivered, we sought to utilise the nfsB (nitroreductase) gene 
fused to mCherry to specifically ablate zebrafish macrophages. 
fms/mpx transgenic embryos were incubated in Metronidazole, which is metabolized 
by nitroreductase to a toxic metabolite, inducing cell death in transgene expressing 
cells. Metronidazole treatment effectively abolished macrophages, without 
significantly altering neutrophil numbers (Fig 8). 
 
Discussion 
In this paper we describe generation of a novel zebrafish transgenic that drives Gal4-
VP16 under the control of the fms promoter. Although it is rare to identify a single 
marker that alone defines a specific cell type with complete specificity, we chose fms 
as the best candidate available. Within the immune system, expression of fms appears 
to be completely restricted to macrophages, and this is critical for studies where 
distinction between different myeloid cell populations is important. fms:nfsB.mCherry 
also labels xanthophores, but their morphology, static nature and superficial location 
allowed discrimination between these and the motile macrophages with complete 
confidence, particularly during timelapse imaging. Since we generated this line, 
subsequent work has identified a number of other possible macrophage specific genes 
(41) that represent good candidates to drive macrophage specific transgenes. A panel 
of transgenic zebrafish using different macrophage specific promoters would allow 
detailed study of the phenotypes of different macrophage subtypes in vivo, and the 
fms transgenic we described would be an important contributor to this approach. 
 
Several pieces of evidence support our conclusion that the putative macrophages 
identified in fms:nfsB.mCherry are indeed macrophages. The expression pattern of the 
transgene recapitulates fms expression defined by in situ hybridization in earlier 
studies. Although fms expression by in situ hybridization can be detected as early as 
19hpf (42), the delay in mCherry expression in the transgenic is likely to represent the 
time taken to express, transcribe and fold sufficient mCherry for detection by 
microscopy. Our data shows that these cells arise from a myeloid origin. The labelled 
cells are clearly not thrombocytes, since we observed no circulating labelled cells. 
Equally, they are not neutrophils since we have never seen co-expression in 
compound transgenics containing the mpx:GFP transgene, but they are clearly 
phagocytic. Taken together with their migratory capacity, these data strongly suggest 
that the labelled cells identified in our transgenic are macrophages, although we 
cannot rule out the possibility that not all macrophages express the transgene. 
 
In keeping with their distinct identities, we observed marked differences in migration 
speed and kinetics of recruitment to a site of tissue injury between neutrophils and 
macrophages. Limited data exists on intravital comparisons of this type, 
demonstrating the utility of our model for such studies. In addition, examination of 
high power, fast frame rate timelapse videomicrographs reveals complex interactions 
between macrophages and neutrophils. Further study of these interactions, made 
possible using these compound transgenics, is likely to inform our knowledge of 
immune cell recruitment and cross-talk. 
 
The ability to visualize both endothelial cells and macrophages in the developing 
embryo revealed a preferred pathway for macrophages along the abluminal surface of 
endothelial cells. This was reminiscent of the luminal patrolling monocytes described 
in mice (43), although we never observed zebrafish macrophages transmigrate 
endothelium, and the endothelium along which they migrated was frequently of 
developing vessels that had not yet lumenized and carried no blood flow. Given the 
role of macrophages in tumour angiogenesis (44), and the impairment of angiogenesis 
in pu.1 deficient mice (40) we speculate that this behaviour may contribute to 
embryonic vascular development in some way. 
 
The explanation for the novel finding that macrophages migrate faster when in 
contact with endothelium is unclear. These macrophages are unlikely to represent a 
separate subset as they frequently leave the endothelium (leading to slowed migration 
speed) or join the endothelium from the tissue (leading to increased migration speed). 
This suggests that some cue from the endothelium allows macrophages to migrate 
more rapidly. A preference for using abluminal endothelium to migrate would be 
compatible with the surveillance functions of macrophages and is noteworthy given 
the important role of the macrophage in many vascular diseases (3-5). 
 
A major advantage of the Gal4/UAS approach to generating transgenics is the ability 
to manipulate macrophage function by driving expression of functional proteins in 
addition to reporter proteins. This is facilitated by the ease by which small construct 
transgenic lines can be generated using the Tol2 approach (45). We illustrated this 
approach by using a nitroreductase/metronidazole lineage ablation strategy. In this 
way, macrophages can be ablated while other immune cell populations are 
maintained. This opens the way for a wide range of studies expressing other 
functional constructs such as chemokines in the macrophage. 
 
There are suggestions from the literature that transcriptional silencing of UAS 
promoters may limit the usefulness of Gal4/UAS zebrafish transgenics (46). 
However, this has not proved a practical problem in our studies. It may be that 
subsequent generations of these UAS transgenics may be less effective, but given the 
ease with which new lines can now be made using the tol2kit system this may not 
prove overly problematic for future work.  
 
Intravital imaging of the inflammatory response has the ability to inform a wide range 
of scientific and clinical questions across a number of fields. The addition of zebrafish 
to existing models broadens the ways in which these questions can be approached. 
Our data show how imaging of multiple cell populations in vivo can reveal 
unsuspected interactions, and how delivering functional proteins to macrophages can 
be used to manipulate defined aspects of the immune response. This is likely to 
increase our understanding of the behaviour and interaction of these essential cell 
populations in vivo. 
 
Acknowledgements 
We are extremely grateful to Dr Stone Elworthy for assistance in generating the BAC 
construct and to the aquarium staff of the MRC Centre for Developmental and 
Biomedical Genetics for their expert husbandry. 
 
References 1. Soehnlein O, Lindbom L. Phagocyte partnership during the onset and resolution of inflammation. Nat Rev Immunol 2010 Jun;10(6):427-39. 2. Soehnlein O, Weber C. Myeloid cells in atherosclerosis: initiators and decision shapers. Semin Immunopathol 2009 Jun;31(1):35-47. 3. Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 2005 Apr 21;352(16):1685-95. 
4. Libby P. Inflammation in atherosclerosis. Nature 2002 Dec 19-26;420(6917):868-74. 5. Weber C, Schober A, Zernecke A. Chemokines: key regulators of mononuclear cell recruitment in atherosclerotic vascular disease. Arterioscler Thromb Vasc Biol 2004 Nov;24(11):1997-2008. 6. Renshaw SA, Loynes CA, Trushell DM, et al. A transgenic zebrafish model of neutrophilic inflammation. Blood 2006 Dec 15;108(13):3976-8. 7. Niethammer P, Grabher C, Look AT, et al. A tissue-scale gradient of hydrogen peroxide mediates rapid wound detection in zebrafish. Nature 2009 Jun 18;459(7249):996-9. 8. Hall C, Flores MV, Chien A, et al. Transgenic zebrafish reporter lines reveal conserved Toll-like receptor signaling potential in embryonic myeloid leukocytes and adult immune cell lineages. J Leukoc Biol 2009 May;85(5):751-65. 9. Cvejic A, Hall C, Bak-Maier M, et al. Analysis of WASp function during the wound inflammatory response--live-imaging studies in zebrafish larvae. J Cell Sci 2008 Oct 1;121(Pt 19):3196-206. 10. Le Guyader D, Redd MJ, Colucci-Guyon E, et al. Origins and unconventional behavior of neutrophils in developing zebrafish. Blood 2008 Jan 1;111(1):132-41. 11. Chico TJ, Ingham PW, Crossman DC. Modeling cardiovascular disease in the zebrafish. Trends Cardiovasc Med 2008 May;18(4):150-5. 12. Lieschke GJ, Currie PD. Animal models of human disease: zebrafish swim into view. Nat Rev Genet 2007 May;8(5):353-67. 13. Gray C, Packham IM, Wurmser F, et al. Ischemia is not required for arteriogenesis in zebrafish embryos. Arterioscler Thromb Vasc Biol 2007 Oct;27(10):2135-41. 14. Kelenyi G, Larsen LO. The haematopoietic supraneural organ of adult, sexually immature river lampreys (Lampetra fluviatilis [L.] Gray) with particular reference to azurophil leucocytes. Acta Biol Acad Sci Hung 1976;27(1):45-56. 15. Ellett F, Lieschke GJ. Zebrafish as a model for vertebrate hematopoiesis. Curr Opin Pharmacol 2010 Jun 8. 16. Herbomel P, Thisse B, Thisse C. Ontogeny and behaviour of early macrophages in the zebrafish embryo. Development 1999 Sep;126(17):3735-45. 17. Naito M. Macrophage differentiation and function in health and disease. Pathol Int 2008 Mar;58(3):143-55. 18. Hsu K, Traver D, Kutok JL, et al. The pu.1 promoter drives myeloid gene expression in zebrafish. Blood 2004 Sep 1;104(5):1291-7. 19. Peri F, Nusslein-Volhard C. Live imaging of neuronal degradation by microglia reveals a role for v0-ATPase a1 in phagosomal fusion in vivo. Cell 2008 May 30;133(5):916-27. 20. Ward AC, McPhee DO, Condron MM, et al. The zebrafish spi1 promoter drives myeloid-specific expression in stable transgenic fish. Blood 2003 Nov 1;102(9):3238-40. 21. Mathias JR, Perrin BJ, Liu TX, et al. Resolution of inflammation by retrograde chemotaxis of neutrophils in transgenic zebrafish. J Leukoc Biol 2006 Dec;80(6):1281-8. 22. Meijer AH, van der Sar AM, Cunha C, et al. Identification and real-time imaging of a myc-expressing neutrophil population involved in inflammation and 
mycobacterial granuloma formation in zebrafish. Dev Comp Immunol 2008;32(1):36-49. 23. Hall C, Flores MV, Storm T, et al. The zebrafish lysozyme C promoter drives myeloid-specific expression in transgenic fish. BMC Dev Biol 2007;7:42. 24. Redd MJ, Kelly G, Dunn G, et al. Imaging macrophage chemotaxis in vivo: studies of microtubule function in zebrafish wound inflammation. Cell Motil Cytoskeleton 2006 Jul;63(7):415-22. 25. Lawson ND, Weinstein BM. In vivo imaging of embryonic vascular development using transgenic zebrafish. Dev Biol 2002 Aug 15;248(2):307-18. 26. Burnett SH, Kershen EJ, Zhang J, et al. Conditional macrophage ablation in transgenic mice expressing a Fas-based suicide gene. J Leukoc Biol 2004 Apr;75(4):612-23. 27. Sasmono RT, Oceandy D, Pollard JW, et al. A macrophage colony-stimulating factor receptor-green fluorescent protein transgene is expressed throughout the mononuclear phagocyte system of the mouse. Blood 2003 Feb 1;101(3):1155-63. 28. Crowhurst MO, Layton JE, Lieschke GJ. Developmental biology of zebrafish myeloid cells. Int J Dev Biol 2002;46(4):483-92. 29. Suster ML, Kikuta H, Urasaki A, et al. Transgenesis in zebrafish with the tol2 transposon system. Methods Mol Biol 2009;561:41-63. 30. Villefranc JA, Amigo J, Lawson ND. Gateway compatible vectors for analysis of gene function in the zebrafish. Dev Dyn 2007 Nov;236(11):3077-87. 31. Halpern ME, Rhee J, Goll MG, et al. Gal4/UAS transgenic tools and their application to zebrafish. Zebrafish 2008 Summer;5(2):97-110. 32. Mullins M. Genetic methods: conventions for naming zebrafish genes. In: Westerfield M, editor. The Zebrafish Book. 3rd ed. University of Oregon Press; 1995; 7.1-7.4. 33. Lee EC, Yu D, Martinez de Velasco J, et al. A highly efficient Escherichia coli-based chromosome engineering system adapted for recombinogenic targeting and subcloning of BAC DNA. Genomics 2001 Apr 1;73(1):56-65. 34. McLeish JA, Chico TJ, Taylor HB, et al. Skin exposure to micro- and nano-particles can cause haemostasis in zebrafish larvae. Thromb Haemost 2010 Mar 31;103(4):797-807. 35. Pisharath H, Parsons MJ. Nitroreductase-mediated cell ablation in transgenic zebrafish embryos. Methods Mol Biol 2009;546:133-43. 36. Prajsnar TK, Cunliffe VT, Foster SJ, et al. A novel vertebrate model of Staphylococcus aureus infection reveals phagocyte-dependent resistance of zebrafish to non-host specialized pathogens. Cell Microbiol 2008 Nov;10(11):2312-25. 37. Loynes CA, Martin JS, Robertson A, et al. Pivotal Advance: Pharmacological manipulation of inflammation resolution during spontaneously resolving tissue neutrophilia in the zebrafish. J Leukoc Biol 2010 Feb;87(2):203-12. 38. Alstergren P, Zhu B, Glogauer M, et al. Polarization and directed migration of murine neutrophils is dependent on cell surface expression of CD44. Cell Immunol 2004 Sep-Oct;231(1-2):146-57. 39. Gong Y, Hart E, Shchurin A, et al. Inflammatory macrophage migration requires MMP-9 activation by plasminogen in mice. J Clin Invest 2008 Sep;118(9):3012-24. 
40. Fantin A, Vieira JM, Gestri G, et al. Tissue macrophages act as cellular chaperones for vascular anastomosis downstream of VEGF-mediated endothelial tip cell induction. Blood 2010 Aug 5;116(5):829-40. 41. Zakrzewska A, Cui C, Stockhammer OW, et al. Macrophage-specific gene functions in Spi1-directed innate immunity. Blood 2010 Jul 22;116(3):e1-11. 42. Thisse B, Wright GJ, Thisse C. Embryonic and Larval Expression Patterns from a Large Scale Screening for Novel Low Affinity Extracellular Protein Interactions. ZFIN Direct Data Submission (http://zfinorg) 2008. 43. Auffray C, Fogg D, Garfa M, et al. Monitoring of blood vessels and tissues by a population of monocytes with patrolling behavior. Science 2007 Aug 3;317(5838):666-70. 44. Murdoch C, Muthana M, Coffelt SB, et al. The role of myeloid cells in the promotion of tumour angiogenesis. Nat Rev Cancer 2008 Aug;8(8):618-31. 45. Kwan KM, Fujimoto E, Grabher C, et al. The Tol2kit: a multisite gateway-based construction kit for Tol2 transposon transgenesis constructs. Dev Dyn 2007 Nov;236(11):3088-99. 46. Goll MG, Anderson R, Stainier DY, et al. Transcriptional silencing and reactivation in transgenic zebrafish. Genetics 2009 Jul;182(3):747-55.  
 
Figure Legends 
Figure 1. The fms:nfsB.mCherry transgenic labels two separate populations of 
cells. 
A: Composite DIC (upper panel) and spinning disk confocal micrographs using 
mCherry filters (lower panel) of a 48hpf fms:nfsB.mCherry compound transgenic. 
Sites of imaging for panels B and C are indicated on DIC micrograph. 
Autofluorescence can be seen in the yolk sac, but other fluorescence is located in 
discrete cells. Scale bar = 380um. B: mCherry expression in skin xanthophores, 
showing their typical morphology (Scale bar = 50um). C: mCherry expression in 
macrophages in region of mid-trunk (Scale bar = 50um).  
 
Figure 2. the fms:nfsB.mCherry transgenic labels a population of motile 
macrophage-like cells. 
A: Maximum intensity projections of 1hr confocal timelapse microscopy of 3dpf 
fms:nfsB.mCherry transgenic embryo, acquired at 15min intervals. Scale bar = 50um. 
Macrophages are seen migrating through tissue in the region of the trunk.  Two 
representative cells are arrowed in white and yellow. This sequence is shown in 
Supplemental Movie 1. 
 
Figure 3. pu.1 knockdown abolishes macrophage-like cells while sparing 
xanthophores in the fms:nfsB.mCherry transgenic. 
A: DIC image of 3dpf fms:nfsB.mCherry embryo. Boxed areas indicate regions of 
panels B and C. Scale bar = 200um. B and C: Representative maximum intensity 
projections of confocal micrographs of 3dpf fms:nfsB.mCherry embryos injected with 
control or pu.1 morpholinos imaged over the yolk sac (B) and caudal vein (C). 
Macrophages are labeled with white arrows, xanthophores with yellow arrowheads. 
Scale bars = 100um (A) and 200um (B). Pu.1 knockdown abolishes the macrophage 
population while leaving the xanthophores unaffected. 
 
Figure 4. The fms/mpx transgenic labels separate populations of neutrophils and 
macrophages. 
Confocal microscopy of 3dpf fms/mpx transgenic embryo showing GFP expressing 
neutrophils and mCherry expressing macrophages. Imaging was performed in the 
region of the trunk. No co-expression of either marker was observed. Scale bar = 
17um. This sequence is shown in Supplemental Movie 2. 
 
Figure 5. The fms/mpx transgenic allows simultaneous imaging of recruitment of 
neutrophils and macrophages to a site of tissue injury. 
Timelapse confocal microscopy of 3dpf fms/mpx transgenic embryo showing 
migration of GFP-expressing neutrophils and mCherry-expressing macrophages to a 
site of tailfin injury from 0-14h after injury. An initial neutrophilic response can be 
seen before resolving while macrophage recruitment increases more slowly over time. 
Scale bar = 140um. See also Supplemental Movies 3 and 4. 
 
 
Figure 6. The fms/mpx transgenic reveals marked differences between neutrophil 
and macrophage migration speed and recruitment kinetics. 
A: Timecourse of recruitment of neutrophils and macrophages to a site of tailfin 
injury in 3dpf fms/mpx transgenic embryos. B: Mean migration speed of neutrophils 
and macrophages recruited to a site of tailfin injury. Data indicates mean+/- SEM, 
n=74-105 cells/group. *** indicates p<0.0001 for comparison of neutrophils versus 
macrophages.  
 
Figure 7. Macrophages are closely apposed to and migrate along the abluminal 
surface of endothelium. 
A Caudal vein of compound fms/fli1 embryo. Upper panel; GFP expression in 
endothelium, Middle panel; Macrophages surrounding caudal vein, Lower panel; 
merged image (Scale bar = 50um). B: Timelapse confocal microscopy of 3dpf fms/fli1 
transgenic embryo (scale bar = 70um), showing migration along the abluminal 
endothelium in the trunk. Timestamp indicates minutes between frames shown. 
Individual macrophages are arrowed in yellow and white. C: Migration speeds of 
macrophages in contact with endothelium compared with macrophages in the tissue. 
Data is expressed as mean +/- SEM. p<0.001. 
 
Figure 8. Metronidazole specifically ablates macrophages without affecting 
neutrophils in fms/mpx transgenics. 
The effect of Metronidazole on macrophage and neutrophil recruitment to a site of 
tailfin injury in 3dpf fms/mpx embryos 7h post injury. A: representative 
photomicrographs of fms/mpx embryos treated with control or 5mM Metronidazole 
showing abolition of macrophages. Scale bar = 130um. B: Quantification of 
macrophage and neutrophil recruitment to the site of tailfin injury in fms/mpx 
embryos treated for 15h with 5mM Metronidazole or control. Data indicates mean +/- 
SEM. *** indicates p<0.0001.  
 
Supplemental movie 1. Timelapse confocal microscopy of 3dpf fms:nfsB.mCherry 
transgenic embryo showing migration of macrophages through tissue in region of 
trunk. 
 
Supplemental movie 2. Timelapse confocal microscopy of 3dpf fms/mpx transgenic 
embryo showing migration of GFP expressing neutrophils and mCherry expressing 
macrophages. Macrophages can be seen phagocytosing cell debris (example arrowed) 
No co-expression of either marker was observed. Scale bar = 17um. 
 
Supplemental movie 3. Lower magnification timelapse confocal microscopy of 3dpf 
fms/mpx transgenic embryo showing GFP expressing neutrophils and mCherry 
expressing macrophages migrating to a site of tailfin injury from 0-12h post injury. 
Frames acquired every 60sec. 
 
Supplemental movie 4. Higher magnification timelapse confocal microscopy of 3dpf 
fms/mpx transgenic embryo showing GFP expressing neutrophils and mCherry 
expressing macrophages migrating to a site of tailfin injury. Scale bar = 70um. 
Frames acquired every 10sec for 80min. 
 
 
Supplemental movie 5. Timelapse confocal microscopy of 3dpf fms/fli1 transgenic 
embryo showing GFP expressing endothelium and mCherry expressing macrophages. 
Macrophages can be seen migrating along the abluminal surface of the developing 
vasculature. 
 
